Great NOCC overview on maintenance therapy for ovarian cancer.
Zejula Improves Progression-Free Survival in Ovarian Cancer
Understand the symptoms, risk factors, diagnosis, tests and the role of screening and early detection of ovarian cancer.
According to Lancet publication: PI3K - PARP inhibitor combination promising in ovarian cancer - future study warranted
Survival at 2 years was 72.4% versus 40.9% with chemotherapy alone
Maintenance Therapy with Votrient Provides Benefit in Advanced Ovarian Cancer
Understand the role of surgery, chemotherapy, and precision cancer medicines in the treatment of Ovarian Cancer.
There is no longer a “one-size-fits-all” approach to ovarian cancer treatment update on precision cancer medicines.
Chemotherapy and maintenance therapy options for recurrent ovarian cancer.
Stay Current With Ovarian Cancer Treatment Advances & Connect with Others